SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-15-010759
Filing Date
2015-02-17
Accepted
2015-02-17 06:14:11
Documents
1
Group Members
BARBARA N. LUBASHBRADLEY J. BOLZONBRIAN G. ATWOODCHARLES M. WARDENDONALD B. MILDERREBECCA B. ROBERTSONROSS A. JAFFESAMUEL D. COLELLAVERSANT SIDE FUND II, L.P.VERSANT VENTURE CAPITAL II, L.P.VERSANT VENTURES II, LLCWILLIAM J. LINK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a15-4513_5sc13ga.htm SC 13G/A 412639
  Complete submission text file 0001104659-15-010759.txt   414786
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87950 | Film No.: 15617641
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-7877
Versant Affiliates Fund II-A, LP (Filed by) CIK: 0001354132 (see all company filings)

IRS No.: 943410106 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A